Global and United States Oral Contraceptive Market Report & Forecast 2022-2028

Global and United States Oral Contraceptive Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Oral Contraceptive Product Introduction
1.2 Global Oral Contraceptive Outlook 2017 VS 2022 VS 2028
1.2.1 Global Oral Contraceptive Sales in US$ Million for the Year 2017-2028
1.2.2 Global Oral Contraceptive Sales in Volume for the Year 2017-2028
1.3 United States Oral Contraceptive Outlook 2017 VS 2022 VS 2028
1.3.1 United States Oral Contraceptive Sales in US$ Million for the Year 2017-2028
1.3.2 United States Oral Contraceptive Sales in Volume for the Year 2017-2028
1.4 Oral Contraceptive Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Oral Contraceptive in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Oral Contraceptive Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Oral Contraceptive Market Dynamics
1.5.1 Oral Contraceptive Industry Trends
1.5.2 Oral Contraceptive Market Drivers
1.5.3 Oral Contraceptive Market Challenges
1.5.4 Oral Contraceptive Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Oral Contraceptive Market Segment by Type
2.1.1 Combination
2.1.2 Progestin Only
2.1.3 Others
2.2 Global Oral Contraceptive Market Size by Type
2.2.1 Global Oral Contraceptive Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Oral Contraceptive Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Oral Contraceptive Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Oral Contraceptive Market Size by Type
2.3.1 United States Oral Contraceptive Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Oral Contraceptive Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Oral Contraceptive Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Oral Contraceptive Market Segment by Application
3.1.1 Male
3.1.2 Female
3.2 Global Oral Contraceptive Market Size by Application
3.2.1 Global Oral Contraceptive Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Oral Contraceptive Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Oral Contraceptive Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Oral Contraceptive Market Size by Application
3.3.1 United States Oral Contraceptive Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Oral Contraceptive Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Oral Contraceptive Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Oral Contraceptive Competitor Landscape by Company
4.1 Global Oral Contraceptive Market Size by Company
4.1.1 Top Global Oral Contraceptive Manufacturers Ranked by Revenue (2021)
4.1.2 Global Oral Contraceptive Revenue by Manufacturer (2017-2022)
4.1.3 Global Oral Contraceptive Sales by Manufacturer (2017-2022)
4.1.4 Global Oral Contraceptive Price by Manufacturer (2017-2022)
4.2 Global Oral Contraceptive Concentration Ratio (CR)
4.2.1 Oral Contraceptive Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Oral Contraceptive in 2021
4.2.3 Global Oral Contraceptive Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Oral Contraceptive Manufacturing Base Distribution, Product Type
4.3.1 Global Oral Contraceptive Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Oral Contraceptive Product Type
4.3.3 Date of International Manufacturers Enter into Oral Contraceptive Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Oral Contraceptive Market Size by Company
4.5.1 Top Oral Contraceptive Players in United States, Ranked by Revenue (2021)
4.5.2 United States Oral Contraceptive Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Oral Contraceptive Sales by Players (2020, 2021 & 2022)
5 Global Oral Contraceptive Market Size by Region
5.1 Global Oral Contraceptive Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Oral Contraceptive Market Size in Volume by Region (2017-2028)
5.2.1 Global Oral Contraceptive Sales in Volume by Region: 2017-2022
5.2.2 Global Oral Contraceptive Sales in Volume Forecast by Region (2023-2028)
5.3 Global Oral Contraceptive Market Size in Value by Region (2017-2028)
5.3.1 Global Oral Contraceptive Sales in Value by Region: 2017-2022
5.3.2 Global Oral Contraceptive Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Oral Contraceptive Market Size YoY Growth 2017-2028
6.1.2 North America Oral Contraceptive Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Oral Contraceptive Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Oral Contraceptive Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Oral Contraceptive Market Size YoY Growth 2017-2028
6.3.2 Europe Oral Contraceptive Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Oral Contraceptive Market Size YoY Growth 2017-2028
6.4.2 Latin America Oral Contraceptive Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Oral Contraceptive Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Oral Contraceptive Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Pfizer, Inc.
7.1.1 Pfizer, Inc. Corporation Information
7.1.2 Pfizer, Inc. Description and Business Overview
7.1.3 Pfizer, Inc. Oral Contraceptive Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Pfizer, Inc. Oral Contraceptive Products Offered
7.1.5 Pfizer, Inc. Recent Development
7.2 Bayer AG
7.2.1 Bayer AG Corporation Information
7.2.2 Bayer AG Description and Business Overview
7.2.3 Bayer AG Oral Contraceptive Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Bayer AG Oral Contraceptive Products Offered
7.2.5 Bayer AG Recent Development
7.3 Merck & Co., Inc.
7.3.1 Merck & Co., Inc. Corporation Information
7.3.2 Merck & Co., Inc. Description and Business Overview
7.3.3 Merck & Co., Inc. Oral Contraceptive Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Merck & Co., Inc. Oral Contraceptive Products Offered
7.3.5 Merck & Co., Inc. Recent Development
7.4 Janssen Global Services, LLC
7.4.1 Janssen Global Services, LLC Corporation Information
7.4.2 Janssen Global Services, LLC Description and Business Overview
7.4.3 Janssen Global Services, LLC Oral Contraceptive Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Janssen Global Services, LLC Oral Contraceptive Products Offered
7.4.5 Janssen Global Services, LLC Recent Development
7.5 Mankind Pharma Ltd.
7.5.1 Mankind Pharma Ltd. Corporation Information
7.5.2 Mankind Pharma Ltd. Description and Business Overview
7.5.3 Mankind Pharma Ltd. Oral Contraceptive Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Mankind Pharma Ltd. Oral Contraceptive Products Offered
7.5.5 Mankind Pharma Ltd. Recent Development
7.6 Teva Pharmaceutical Industries Ltd
7.6.1 Teva Pharmaceutical Industries Ltd Corporation Information
7.6.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
7.6.3 Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Teva Pharmaceutical Industries Ltd Oral Contraceptive Products Offered
7.6.5 Teva Pharmaceutical Industries Ltd Recent Development
7.7 Allergan, plc (Actavis)
7.7.1 Allergan, plc (Actavis) Corporation Information
7.7.2 Allergan, plc (Actavis) Description and Business Overview
7.7.3 Allergan, plc (Actavis) Oral Contraceptive Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Allergan, plc (Actavis) Oral Contraceptive Products Offered
7.7.5 Allergan, plc (Actavis) Recent Development
7.8 Piramal Enterprises Ltd.
7.8.1 Piramal Enterprises Ltd. Corporation Information
7.8.2 Piramal Enterprises Ltd. Description and Business Overview
7.8.3 Piramal Enterprises Ltd. Oral Contraceptive Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Piramal Enterprises Ltd. Oral Contraceptive Products Offered
7.8.5 Piramal Enterprises Ltd. Recent Development
7.9 Beijing Zizhu Pharm
7.9.1 Beijing Zizhu Pharm Corporation Information
7.9.2 Beijing Zizhu Pharm Description and Business Overview
7.9.3 Beijing Zizhu Pharm Oral Contraceptive Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Beijing Zizhu Pharm Oral Contraceptive Products Offered
7.9.5 Beijing Zizhu Pharm Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Oral Contraceptive Industry Chain Analysis
8.2 Oral Contraceptive Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Oral Contraceptive Distributors
8.3 Oral Contraceptive Production Mode & Process
8.4 Oral Contraceptive Sales and Marketing
8.4.1 Oral Contraceptive Sales Channels
8.4.2 Oral Contraceptive Distributors
8.5 Oral Contraceptive Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Oral Contraceptive CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Oral Contraceptive Market Trends
Table 3. Oral Contraceptive Market Drivers
Table 4. Oral Contraceptive Market Challenges
Table 5. Oral Contraceptive Market Restraints
Table 6. Global Oral Contraceptive Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Oral Contraceptive Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Oral Contraceptive Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Oral Contraceptive Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Oral Contraceptive Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Oral Contraceptive Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Oral Contraceptive Revenue Share by Manufacturer, 2017-2022
Table 13. Global Oral Contraceptive Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Oral Contraceptive Sales Share by Manufacturer, 2017-2022
Table 15. Global Oral Contraceptive Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Oral Contraceptive Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Oral Contraceptive by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Contraceptive as of 2021)
Table 18. Top Players of Oral Contraceptive in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Oral Contraceptive Product Type
Table 20. Date of International Manufacturers Enter into Oral Contraceptive Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Oral Contraceptive Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Oral Contraceptive Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Oral Contraceptive Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Oral Contraceptive Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Oral Contraceptive Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Oral Contraceptive Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Oral Contraceptive Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Oral Contraceptive Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Oral Contraceptive Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Oral Contraceptive Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Oral Contraceptive Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Oral Contraceptive Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Oral Contraceptive Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Oral Contraceptive Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Oral Contraceptive Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Oral Contraceptive Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Oral Contraceptive Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Oral Contraceptive Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Oral Contraceptive Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Oral Contraceptive Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Pfizer, Inc. Corporation Information
Table 43. Pfizer, Inc. Description and Business Overview
Table 44. Pfizer, Inc. Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Pfizer, Inc. Oral Contraceptive Product
Table 46. Pfizer, Inc. Recent Development
Table 47. Bayer AG Corporation Information
Table 48. Bayer AG Description and Business Overview
Table 49. Bayer AG Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Bayer AG Product
Table 51. Bayer AG Recent Development
Table 52. Merck & Co., Inc. Corporation Information
Table 53. Merck & Co., Inc. Description and Business Overview
Table 54. Merck & Co., Inc. Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Merck & Co., Inc. Product
Table 56. Merck & Co., Inc. Recent Development
Table 57. Janssen Global Services, LLC Corporation Information
Table 58. Janssen Global Services, LLC Description and Business Overview
Table 59. Janssen Global Services, LLC Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Janssen Global Services, LLC Product
Table 61. Janssen Global Services, LLC Recent Development
Table 62. Mankind Pharma Ltd. Corporation Information
Table 63. Mankind Pharma Ltd. Description and Business Overview
Table 64. Mankind Pharma Ltd. Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Mankind Pharma Ltd. Product
Table 66. Mankind Pharma Ltd. Recent Development
Table 67. Teva Pharmaceutical Industries Ltd Corporation Information
Table 68. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 69. Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Teva Pharmaceutical Industries Ltd Product
Table 71. Teva Pharmaceutical Industries Ltd Recent Development
Table 72. Allergan, plc (Actavis) Corporation Information
Table 73. Allergan, plc (Actavis) Description and Business Overview
Table 74. Allergan, plc (Actavis) Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Allergan, plc (Actavis) Product
Table 76. Allergan, plc (Actavis) Recent Development
Table 77. Piramal Enterprises Ltd. Corporation Information
Table 78. Piramal Enterprises Ltd. Description and Business Overview
Table 79. Piramal Enterprises Ltd. Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Piramal Enterprises Ltd. Product
Table 81. Piramal Enterprises Ltd. Recent Development
Table 82. Beijing Zizhu Pharm Corporation Information
Table 83. Beijing Zizhu Pharm Description and Business Overview
Table 84. Beijing Zizhu Pharm Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Beijing Zizhu Pharm Product
Table 86. Beijing Zizhu Pharm Recent Development
Table 87. Key Raw Materials Lists
Table 88. Raw Materials Key Suppliers Lists
Table 89. Oral Contraceptive Customers List
Table 90. Oral Contraceptive Distributors List
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Contraceptive Product Picture
Figure 2. Global Oral Contraceptive Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Oral Contraceptive Market Size 2017-2028 (US$ Million)
Figure 4. Global Oral Contraceptive Sales 2017-2028 (K Units)
Figure 5. United States Oral Contraceptive Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Oral Contraceptive Market Size 2017-2028 (US$ Million)
Figure 7. United States Oral Contraceptive Sales 2017-2028 (K Units)
Figure 8. United States Oral Contraceptive Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Oral Contraceptive Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Oral Contraceptive Report Years Considered
Figure 11. Product Picture of Combination
Figure 12. Product Picture of Progestin Only
Figure 13. Product Picture of Others
Figure 14. Global Oral Contraceptive Market Share by Type in 2022 & 2028
Figure 15. Global Oral Contraceptive Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Oral Contraceptive Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Oral Contraceptive Sales by Type (2017-2028) & (K Units)
Figure 18. Global Oral Contraceptive Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Oral Contraceptive Price by Type (2017-2028) & (USD/Unit)
Figure 20. United States Oral Contraceptive Market Share by Type in 2022 & 2028
Figure 21. United States Oral Contraceptive Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Oral Contraceptive Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Oral Contraceptive Sales by Type (2017-2028) & (K Units)
Figure 24. United States Oral Contraceptive Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Oral Contraceptive Price by Type (2017-2028) & (USD/Unit)
Figure 26. Product Picture of Male
Figure 27. Product Picture of Female
Figure 28. Global Oral Contraceptive Market Share by Application in 2022 & 2028
Figure 29. Global Oral Contraceptive Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Oral Contraceptive Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Oral Contraceptive Sales by Application (2017-2028) & (K Units)
Figure 32. Global Oral Contraceptive Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Oral Contraceptive Price by Application (2017-2028) & (USD/Unit)
Figure 34. United States Oral Contraceptive Market Share by Application in 2022 & 2028
Figure 35. United States Oral Contraceptive Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Oral Contraceptive Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Oral Contraceptive Sales by Application (2017-2028) & (K Units)
Figure 38. United States Oral Contraceptive Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Oral Contraceptive Price by Application (2017-2028) & (USD/Unit)
Figure 40. North America Oral Contraceptive Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 41. North America Oral Contraceptive Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Oral Contraceptive Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 45. Europe Oral Contraceptive Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Oral Contraceptive Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 52. Asia-Pacific Oral Contraceptive Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Oral Contraceptive Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 64. Latin America Oral Contraceptive Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Oral Contraceptive Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 69. Middle East & Africa Oral Contraceptive Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. UAE Oral Contraceptive Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Oral Contraceptive Value Chain
Figure 74. Oral Contraceptive Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119

According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......

Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......

Global Contraceptives Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141

According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......

Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108

According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......

Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99

Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......

Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139

Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......

Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122

Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......

Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108

Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......

Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs